The CancerCare Co-Payment Assistance Foundation currently has funds covering the following diagnoses:
| Sorted By Generic Name |
Sorted By Brand Name |
| Generic |
Brand |
| anastrozole |
Arimidex |
| bevacuzimab |
Avastin |
| carboplatin |
Paraplatin |
| capecitabine |
Xeloda |
| cyclophosphamide |
Cytoxan |
| dexrazoxane |
Zinecard |
| docetaxel |
Taxotere |
| doxorubicin |
Adriamycin PFS |
| epirubicin |
Ellence |
| epirubicin hcl |
epirubicin hcl |
| eribulin mesylate |
Halaven |
| exemestane |
Aromasin |
| fluorouracil, 5-FU |
Adrucil |
| fulvestrant |
Faslodex |
| ixabepilone |
Ixempra |
| goserelin acetate |
Zoladex Implant |
| goserelin acetate |
Zoladex Implant |
| lapatinib ditosylate |
Tykerb |
| letrozole |
Femara |
| mitomycin C |
Mitozytrex |
| paclitaxel |
Abraxane |
| paclitaxel |
Taxol |
| tamoxifen |
Nolvadex |
| toremifene |
Fareston |
| trastuzumab |
Herceptin |
| vinorelbine |
Navelbine |
|
| Brand |
Generic |
| Abraxane |
paclitaxel |
| Adriamycin PFS |
doxorubicin |
| Adrucil |
fluorouracil, 5-FU |
| Arimidex |
anastrozole |
| Aromasin |
exemestane |
| Avastin |
bevacuzimab |
| Cytoxan |
cyclophosphamide |
| Ellence |
epirubicin |
| epirubicin hcl |
epirubicin hcl |
| Fareston |
toremifene |
| Faslodex |
fulvestrant |
| Femara |
letrozole |
| Ixempra |
ixabepilone |
| Gemzar |
gemcitabine |
| Halaven |
eribulin mesylate |
| Herceptin |
trastuzumab |
| Mitozytrex |
mitomycin C |
| Navelbine |
vinorelbine |
| Nolvadex |
carboplatin |
| Paraplatin |
tamoxifen |
| Taxol |
paclitaxel |
| Taxotere |
docetaxel |
| Tykerb |
lapatinib ditosylate |
| Xeloda |
capecitabine |
| Zinecard |
dexrazoxane |
| Zoladex Implant |
goserelin acetate |
|
| Sorted By Generic Name |
Sorted By Brand Name |
| Generic |
Brand |
| bevacuzimab |
Avastin |
| capecitabine |
Xeloda |
| cetuximab |
Erbitux |
| fluorouracil, 5-FU |
Adrucil |
| irinotecan |
Camptosar |
| leucovorin |
Wellcovorin, Leucovorin |
| levamisole |
Ergamisol |
| oxaliplatin |
Eloxatin |
| panitumumab |
Vectibix |
|
| Brand |
Generic |
Adrucil |
fluorouracil, 5-FU |
| Avastin |
bevacuzimab |
| Camptosar |
irinotecan |
| Eloxatin |
oxaliplatin |
| Erbitux |
cetuximab |
| Ergamisol |
levamisole |
| Vectibix |
panitumumab |
| Wellcovorin, Leucovorin |
leucovorin |
| Xeloda |
capecitabine |
|
| Sorted By Generic Name |
Sorted By Brand Name |
| Generic |
Brand |
| capecitabine |
Xeloda |
| cisplatin |
Platinol |
| doxorubicin |
Adriamycin PFS |
| fluorouracil 5-FU |
Adrucil |
| mitomycin |
Mutamycin |
| trastuzumab |
Herceptin |
|
| Brand |
Generic |
| Adriamycin PFS |
doxorubicin |
| Adrucil |
fluorouracil 5-FU |
| Herceptin |
trastuzumab |
| Mutamycin |
mitomycin |
| Platinol |
cisplatin |
| Xeloda |
capecitabine |
|
| Sorted By Generic Name |
Sorted By Brand Name |
| Generic |
Brand |
| bevacizumab |
Avastin |
| carmustine with prolifeprosan 20 implant |
Gliadel Wafter implant |
| temozolomide capsules |
Temodar |
|
| Brand |
Generic |
| Avastin |
bevacizumab |
| Gliadel Wafter implant |
carmustine with prolifeprosan 20 implant |
| Temodar |
temozolomide capsules |
|
| Sorted By Generic Name |
Sorted By Brand Name |
| Generic |
Brand |
| cetuximab |
Erbitux |
| docetaxel |
Taxotere |
|
| Brand |
Generic |
| Erbitux |
cetuximab |
| Taxotere |
docetaxel |
|
| Sorted By Generic Name |
Sorted By Brand Name |
| Generic |
Brand |
| amifostine |
Ethyol |
| bevacuzimab |
Avastin |
| cisplatin |
Platinol |
| carboplatin |
Paraplatin |
| docetaxel |
Taxotere |
| erlotinib |
Tarceva |
| etoposide phosphate |
Etopophos |
| etoposide, VP-16 |
VePesid |
| gefitinib |
Iressa |
| gemcitabine |
Gemzar |
| irinotecan |
Camptosar |
| paclitaxel |
Taxol |
| pemetrexed disodium |
Alimta |
| porfimer sodium |
Photofrin |
| topotecan |
Hycamtin |
| vinorelbine |
Navelbine |
|
| Brand |
Generic |
| Alimta |
pemetrexed disodium |
| Avastin |
bevacuzimab |
| Camptosar |
irinotecan |
| Ethyol |
amifostine |
| Etopophos |
etoposide phosphate |
| Gemzar |
gemcitabine |
| Hycamtin |
topotecan |
| Iressa |
gefitinib |
| Navelbine |
vinorelbine |
| Paraplatin |
carboplatin |
| Platinol |
cisplatin |
| Photofrin |
porfimer sodium |
| Tarceva |
erlotinib |
| Taxol |
paclitaxel |
| Taxotere |
docetaxel |
| VePesid |
etoposide, VP-16 |
|
| Sorted By Generic Name |
Sorted By Brand Name |
| Generic |
Brand |
| capecitabine |
Xeloda |
| erlotinib |
Tarceva |
| gemcitabine |
Gemzar |
| mitomycin C |
Mitozytrex |
| streptozocin |
Zanosar |
|
| Brand |
Generic |
| Gemzar |
gemcitabine |
| Mitozytrex |
mitomycin C |
| Tarceva |
erlotinib |
| Xeloda |
capecitabine |
| Zanosar |
streptozocin |
|
| Sorted By Generic Name |
Sorted By Brand Name |
| Generic |
Brand |
| abiraterone acetate | Zytiga |
| bicalutamide | Casodex |
| cabazitaxel | Jevtana |
| degarelix | Degarelix |
| docetaxel | Taxotere |
| estramustine | Emcyt |
| goserelin | Zoladex |
| leuprolide acetate | Lupron Depot |
| leuprolide acetate | Eligard |
| mitoxantrone | Novantrone |
| nilutamide | Nilandron |
| triptorelin | Trelstar |
|
| Brand |
Generic |
| Casodex |
bicalutamide |
| Degarelix |
degarelix |
| Eligard |
leuprolide acetate |
| Emcyt |
estramustine |
| Jevtana |
cabazitaxel |
| Lupron Depot |
leuprolide acetate |
| Nilandron |
nilutamide |
| Novantrone |
mitoxantrone |
| Taxotere |
docetaxel |
| Trelstar |
triptorelin |
| Zoladex |
goserelin |
| Zytiga |
abiraterone acetate |
|
| Sorted By Generic Name |
Sorted By Brand Name |
| Generic |
Brand |
| bevacizumab |
Avastin |
| everolimus |
Afinitor |
| pazopanib |
Votrient |
| sorafenib |
Nexavar |
| sunitinib malate |
Sutent |
| temsirolimus |
Torisel |
|
| Brand |
Generic |
| Afinitor |
everolimus |
| Avastin |
bevacizumab |
| Nexavar |
sorafenib |
| Sutent |
sunitinib malate |
| Torisel |
temsirolimus |
| Votrient |
pazopanib |
|
Only FDA approved medications indicated for your cancer type and certain related costs to administer the medication may be covered. The program does not assist with pain or chemotherapy related symptom management medications and does not assist with radiation costs.
If you have been prescribed a drug or treatment that is not on this list, please contact us and one of our co-payment specialists can review your situation with you.
Please note that diagnoses and medications covered are subject to change with or without notice.